3 amino acids that make up glutathione glutathione

however, further optimization is required to ensure their stability/effectiveness in vivo and safety for use in the human body ( 4.3 Matrix-disrupting adjuvants and enzymatic dispersal strategies Enzymatic or chemical disruption of the ECM is a potential option for addressing drug sequestration limitations resulting from poor tissue penetration, and it has been extensively studied in the literature

Common pathogens, such as Pseudomonas aeruginosa ( P

based on their mechanisms, a clinically significant interaction affecting absorption, distribution, metabolism, or excretion of either agent seems unlikely

ADVERSE REACTIONS: As with all protein drugs, a small number of patients may develop antibodies to the protein